U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5076029

Helium-Filled Sun Shade

A helium-filled sun shade for protecting individuals engaged in outdoor activities.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/402 - Additional hetero ring


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter which contains an additional hetero ring,
No. of patents: 145
Last issue date: 02/28/2012


1        
NumberTitleIssue Date
8124640Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass. ...
02/28/2012
7595335Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
A pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs. ...
09/29/2009
7410999Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
The present invention relates to novel compounds and methods that are useful in treating members of the Flaviviridae family of viruses. Compounds of the present invention will have a structure according to Formulas (I)-(VI) as recited throughout the application....
08/12/2008
7375125Melanocortin-4 receptor binding compounds and methods of use thereof
Provided are MC4-R binding compounds of the formula XVII: wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, ...
05/20/2008
7371773Breast cancer resistance protein () inhibitor
The invention provides a drug which inhibits BCRP. A breast cancer resistance protein inhibitor containing, as an active ingredient, a diphenylacrylonitrile derivative represented by the following formula (1): [where...
05/13/2008
73686081-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1,4-benzodioxane derivatives
An 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivative represented by the following formula (1), wherein cycle A may have further 1 to 4 substituents, and said substituent means a substituent selected from the group consisti...
05/06/2008
7345078NF-κB inhibitors and uses thereof
A new class of imidazolines as 4-position acids or esters with very potent anti-inflammatory as well as antimicrobial activity is described. The synthesis of these imidazolines includes a multicomponent reaction applicable to a combinatorial synthetic approach. The ...
03/18/2008
7338970Pharmaceutical composition based on a polymorphic form I of idazoxan
Pharmaceutical composition comprising 5 to 20% of an idazoxan salt or of idazoxan hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica and from 29.5% to 84.8% of lactose, with respect to the total mass. ...
03/04/2008
7029706Composition for the treatment of cutaneous mycosis
The inventions relates to the use of silica in the formulation of antifungal composition for the treatment of cutaneous mycoses, and method to manufacture an antifungal powder with boric acid and silica. ...
04/18/2006
6956051Enkephalin conjugates
The present invention relates to amphiphilic drug-oligomer conjugates capable of traversing the blood-brain barrier (“BBB”) and to methods of making and using such conjugates. An amphiphilic drug-oligomer conjugates comprise a therapeutic compound conjugated to ...
10/18/2005
6947365Method for protecting phase lock loop in optical system
A method for protecting a phase lock loop (PLL) in an optical system is disclosed. The disclosed method will determine whether the currently reading data is erroneous and then maintain the frequency currently locked by the PLL circuit when the waveform lengths of th...
09/20/2005
6911478Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
The present invention relates to nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions comprising such compounds, methods of using such compounds and compositions, and to a method for the preparation of nitric oxide-releasing amidine- a...
06/28/2005
6878735Multi-substituted imidazolines and method of use thereof
A new class of imidazolines as 4-position acids or esters with very potent anti-inflammatory as well as antimicrobial activity is described. The synthesis of these imidazolines includes a multicomponent reaction applicable to a combinatorial synthetic approach. The ...
04/12/2005
6852726Substituted indoles as alpha-1 agonists
This invention relates to compounds which are alpha-1 receptor agonists, preferably alpha-1A/L receptor agonists, and which are represented by Formula I: wherein X is —S(O)n— or —C(O)—, A is C1-...
02/08/2005
6835743Pesticidal pyrazoles and derivatives
Process for the protection of a building that has already been built or is going to be built, whereby an effective amount of an insecticidally active compound is spread around or under the said building at discrete locations. The insecticide may be an arylpyrazole.
12/28/2004
6762190Thienylalanine derivatives as inhibitors of cell adhesion
The present invention relates to compounds of formula (I), in which A, B, X, Y, R1, R2, R3 and n have the meanings indicated in the claims. The compounds of formula (I) are valuable pharmacologically active compounds. They are vitron...
07/13/2004
6756395Imidazolinyimethyl aralklsulfonamides
Compounds of the Formula: where R1-R6 are those defined herein and methods for producing the same. Also provided are pharmaceutical compositions comprising a Compound of Formula I and methods for th...
06/29/2004
6743817Substituted fused pyrroleimines and pyrazoleimines
Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof wherein R, Ar, A, n, R1 and R2 are defined herein. These compounds are highly selective agonists, antagonists...
06/01/2004
6720317Inhibitors of factor Xa
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders. ...
04/13/2004
6699862Indolyl-2-phenyl bisamidines useful as antiproliferative agents
Novel indolyl-2-phenyl bisamidines are described which are DNA methyltransferase inhibiting agents, and pharmaceutical compositions containing them are used as antiproliferative agents for treating a disease, especially a neoplastic disease, characterized...
03/02/2004
6680312Sulfonamide derivatives, their production and use
The present invention is to provide a compound or a salt thereof represented by the formula: ##STR1## wherein R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, the ring A is an optionally su...
01/20/2004
6677341(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and m...
01/13/2004
6632815Inhibitors of factor Xa
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders....
10/14/2003
6610725Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
The present invention relates to novel fluorinated benzodioxane imidazoline derivatives, to their preparation and to their therapeutic applications. The invention is directed more particularly toward the compounds corresponding to the structure of general form...
08/26/2003
6596745Method for treating fibrotic diseases with azolium chroman compounds
Provided is a method of treating or ameliorating hypertension in an animal comprising administering an effective amount of a compound of formula I: ##STR1##...
07/22/2003
6528535Bicyclic inhibitors of protein farnesyl transferase
The present invention provide compounds of Formula I ##STR1## The present invention also provides a method of treating cancer and treating or preventing restenosis or atherosclerosis. Also provided by the present invention is a pharmaceutically acceptable...
03/04/2003
6525086Compounds, their preparation and use
The present invention relates to compounds of formula (I) ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, A, X, T, Q, Z, U, Y, Ar, p and n are as defined in the speci...
02/25/2003
6410539Imidazole derivatives and their use as farnesyl protein transferase inhibitors
The present invention relates to a compound of Formula (1) wherein Ar1 represent (A) or (B) or (C); R1 is hydrogen, C1-4 alkyl or C1-4 alkanoyl; R12 and R13 are independently hydrogen or C
06/25/2002
6348464Pyrrolecarbonylimino derivatives as naaladase inhibitors
The present invention relates to pharmaceutical compositions and methods of using pyrrolecarbonylimino derivatives to inhibit N-Acetylated ଱-Linked Acidic Dipeptidase (NAALADase) enzyme activity, thereby effecting neuronal activities, inhibiting ang...
02/19/2002
6331552Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them
Substituted imidazolidine derivatives of the formula I, ##STR1## in which B, E, W, Y, R, R2, R3, R30, e and h have the meanings indicated in the claims. The compounds of the formula I are valuable pharmaceutical active com...
12/18/2001
6319935Conformationally rigid bicyclic and adamantane derivatives useful as 댒-adrenergic blocking agents
A compound of formula I ##STR1## in which: ring A is one of the five alternative multi-cyclic rings as shown wherein a dotted line adjacent to a bond indicates that a single bond or a double bond may be present at that position; X is nitrogen, oxygen or ...
11/20/2001
6232336Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
The present invention relates to nitric oxide-releasing amidine- and enamide-derived diazeniumdiolates, compositions comprising such compounds, methods of using such compounds and compositions, a method for the preparation of nitric oxide-releasing amidin...
05/15/2001
6191159Disubstituted pyrazolines and triazolines as factor Xa inhibitors
The present application describes disubstituted pyrazolines and triazolines of formulae I and II: ##STR1## or pharmaceutically acceptable salt forms thereof, wherein one of M1 and M2 maybe N and D may be a variety of N-containing gro...
02/20/2001
61628182-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
This invention involves compounds having the following structure: ##STR1## wherein: a) R1 is hydrogen; or alkyl; bond (a) is a single or a double bond; b) R2 and R3 are each independently selected from hydrogen; unsub...
12/19/2000
6159998Substituted indoles and uses thereof
This invention is directed to novel indole and benzothiazole compounds which are selective for cloned human alpha 2 receptors. This invention is also related to uses of these compounds for any indication where use of an alpha 2 agonist may be appropriate....
12/12/2000
6153638Use of efaroxan for producing medicine for treating huntington 's disease
The invention concerns the use of efaroxan or therapeutically-acceptable salts, in its racemic form or in the form of an optically-active isomer, for treating Huntington's disease....
11/28/2000
61037444-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists
Disclosed are compounds of the formula ##STR1## wherein: R1 is hydrogen or C1 -C6 alkyl; R2 is selected from hydrogen, straight-chain and branched C1 -C10 alkyl, cyclohexylmethyl or --(CH
08/15/2000
6093727Imidazole and imidazoline derivatives and uses thereof
This invention is directed to novel imidazole and imidazoline derivatives which are selective agonists for cloned human a, adrenergic receptors. This invention is also related to the use of these compounds for the treatment of any disease where modulation...
07/25/2000
6090811Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
A novel use for the class of biologically active bis-heterocyclic, e.g., bis-indole alkaloid compounds, which have been named topsentins, bromotopsentins, homocarbonyltopsentins, nortopsentins, hamacanthins, bis-indole ethylamines, or dragmacidins, pharma...
07/18/2000
6080769Imidazolidin-4-one derivatives useful as anticancer agents
The present invention relates to compounds of formula 1 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein Z, R, R3 and R4 are as defined herein. The invention also relates to pharmaceutical composit...
06/27/2000
1        
 
Sign InRegister
Username  
Password   
forgot password?